Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson's disease

Journal of Clinical Neuroscience

Volumn 15, Issue 8, 2008, Pages 955-956

  Chen, Yen Yu ^a,b   Sy, Hiu Ngar ^a   Wu, Shey Lin ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ZOLPIDEM;

ADULT; AKINESIA; BASAL GANGLION; BEDTIME DOSAGE; BRAIN DEPTH STIMULATION; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; DRUG BINDING SITE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DYSKINESIA; DYSTONIA; GLOBUS PALLIDUS; HUMAN; INSOMNIA; LETTER; MALE; NEUROLOGIC DISEASE; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; SYMPTOM; THALAMOTOMY; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

DYSKINESIAS; DYSTONIA; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PARKINSON DISEASE; PYRIDINES; SEVERITY OF ILLNESS INDEX;

EID: 45949095605     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2007.07.082     Document Type: Letter

References (6)

1. Daniele A., Albanese A., Gainotti G., et al. Zolpidem in Parkinson's disease. Lancet 349 (1997) 1222-1223
2. Daniele A., Moro E., and Bentivoglio A.R. Zolpidem in progressive supranuclear palsy. N Engl J Med 341 (1999) 543-544
3. Evidente V.G. Zolpidem improves dystonia in "Lubag" or X-linked dystonia-parkinsonism syndrome. Neurology 58 (2002) 662-663
4. Ruzicka E., Roth J., Jech R., et al. Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease. Mov Disord 15 (2000) 734-735
5. Langer S.Z., Arbilla S., Scatton B., et al. Receptors involved in the mechanisms of action of zolpidem. In: Sauvanet J.P., Langer S.Z., and Morselli P.L. (Eds). Imidazopyridines in Sleep Disorders (1988), Raven Press, New York 5-70
6. Lang A.E., and Lozano A.M. Parkinson's disease. Second of two parts. N Engl J Med 339 (1998) 1130-1143